These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
384 related articles for article (PubMed ID: 16183664)
21. End of day dyskinesia in advanced Parkinson's disease can be eliminated by bilateral subthalamic nucleus or globus pallidus deep brain stimulation. Apetauerova D; Ryan RK; Ro SI; Arle J; Shils J; Papavassiliou E; Tarsy D Mov Disord; 2006 Aug; 21(8):1277-9. PubMed ID: 16637040 [TBL] [Abstract][Full Text] [Related]
22. Stn-dbs activates the target area in Parkinson disease. Montgomery EB; Hilker R Neurology; 2009 Jul; 73(4):327; author reply 327-8. PubMed ID: 19636056 [No Abstract] [Full Text] [Related]
23. Alleviation of drenching sweats following subthalamic deep brain stimulation in a patient with Parkinson's disease--a case report. Sanghera MK; Ward C; Stewart RM; Mewes K; Simpson RK; Lai EC J Neurol Sci; 2009 Oct; 285(1-2):246-9. PubMed ID: 19616221 [TBL] [Abstract][Full Text] [Related]
24. Treatment of motor and non-motor features of Parkinson's disease with deep brain stimulation. Fasano A; Daniele A; Albanese A Lancet Neurol; 2012 May; 11(5):429-42. PubMed ID: 22516078 [TBL] [Abstract][Full Text] [Related]
25. Bilateral subthalamic nucleus deep brain stimulation improves certain aspects of postural control in Parkinson's disease, whereas medication does not. Shivitz N; Koop MM; Fahimi J; Heit G; Bronte-Stewart HM Mov Disord; 2006 Aug; 21(8):1088-97. PubMed ID: 16671073 [TBL] [Abstract][Full Text] [Related]
26. Pallidal vs subthalamic deep brain stimulation for Parkinson disease: winner and loser or a sharing of honors? Minguez-Castellanos A; Escamilla-Sevilla F Arch Neurol; 2005 Oct; 62(10):1642-3; author reply 1643. PubMed ID: 16216956 [No Abstract] [Full Text] [Related]
27. Pallidal vs subthalamic deep brain stimulation for Parkinson disease. Komotar RJ; Starke RM; Connolly ES; Goodman RR Neurosurgery; 2010 Oct; 67(4):N25-7. PubMed ID: 20881548 [No Abstract] [Full Text] [Related]
29. Subthalamic nucleus stimulation in Parkinson's disease: the other side of the medallion. Temel Y Exp Neurol; 2008 Jun; 211(2):321-3. PubMed ID: 18410927 [No Abstract] [Full Text] [Related]
30. Neuropsychological performance following staged bilateral pallidal or subthalamic nucleus deep brain stimulation for Parkinson's disease. Rothlind JC; Cockshott RW; Starr PA; Marks WJ J Int Neuropsychol Soc; 2007 Jan; 13(1):68-79. PubMed ID: 17166305 [TBL] [Abstract][Full Text] [Related]
31. Anatomy and physiology of the basal ganglia: implications for deep brain stimulation for Parkinson's disease. Kopell BH; Rezai AR; Chang JW; Vitek JL Mov Disord; 2006 Jun; 21 Suppl 14():S238-46. PubMed ID: 16810674 [TBL] [Abstract][Full Text] [Related]
32. Deep-brain stimulation for Parkinson's disease. Okun MS N Engl J Med; 2012 Oct; 367(16):1529-38. PubMed ID: 23075179 [No Abstract] [Full Text] [Related]
33. Electrophysiological mapping for the implantation of deep brain stimulators for Parkinson's disease and tremor. Gross RE; Krack P; Rodriguez-Oroz MC; Rezai AR; Benabid AL Mov Disord; 2006 Jun; 21 Suppl 14():S259-83. PubMed ID: 16810720 [TBL] [Abstract][Full Text] [Related]
34. Deep brain stimulation of the subthalamic nucleus improves set shifting but does not affect dual task performance in Parkinson's disease. Page D; Jahanshahi M IEEE Trans Neural Syst Rehabil Eng; 2007 Jun; 15(2):198-206. PubMed ID: 17601189 [TBL] [Abstract][Full Text] [Related]
35. Prognostic factors of subthalamic stimulation in Parkinson's disease: a comparative study between short- and long-term effects. Tsai ST; Lin SH; Chou YC; Pan YH; Hung HY; Li CW; Lin SZ; Chen SY Stereotact Funct Neurosurg; 2009; 87(4):241-8. PubMed ID: 19556833 [TBL] [Abstract][Full Text] [Related]
36. Stimulation of the caudal zona incerta is superior to stimulation of the subthalamic nucleus in improving contralateral parkinsonism. Plaha P; Ben-Shlomo Y; Patel NK; Gill SS Brain; 2006 Jul; 129(Pt 7):1732-47. PubMed ID: 16720681 [TBL] [Abstract][Full Text] [Related]
37. Deep brain stimulation for Parkinson's disease: prevalence of adverse events and need for standardized reporting. Videnovic A; Metman LV Mov Disord; 2008 Feb; 23(3):343-9. PubMed ID: 17987644 [TBL] [Abstract][Full Text] [Related]
39. Long-term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease. Volkmann J; Albanese A; Kulisevsky J; Tornqvist AL; Houeto JL; Pidoux B; Bonnet AM; Mendes A; Benabid AL; Fraix V; Van Blercom N; Xie J; Obeso J; Rodriguez-Oroz MC; Guridi J; Schnitzler A; Timmermann L; Gironell AA; Molet J; Pascual-Sedano B; Rehncrona S; Moro E; Lang AC; Lozano AM; Bentivoglio AR; Scerrati M; Contarino MF; Romito L; Janssens M; Agid Y Mov Disord; 2009 Jun; 24(8):1154-61. PubMed ID: 19412954 [TBL] [Abstract][Full Text] [Related]
40. Motor and nonmotor symptom follow-up in parkinsonian patients after deep brain stimulation of the subthalamic nucleus. Zibetti M; Torre E; Cinquepalmi A; Rosso M; Ducati A; Bergamasco B; Lanotte M; Lopiano L Eur Neurol; 2007; 58(4):218-23. PubMed ID: 17823535 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]